| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $2,069,198 ) |
| | 2026 | 2026 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01DC000188 | Cochlear synaptopathy in noise-induced and age-related hearing loss: mechanisms and treatments | 000 | 45 | NIH | 2/10/2026 | $671,763 |
| | 2026 | 2026 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01DC018353 | Diverse Cortical Layer 1 Circuits forAuditory Processing and Plasticity | 000 | 6 | NIH | 1/20/2026 | $554,078 |
| | 2026 | 2026 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01EB036978 | Fluorescence lifetime-based intraoperative imaging system for sarcoma surgeries | 000 | 2 | NIH | 12/22/2025 | $480,039 |
| | 2026 | 2026 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | K23EY035734 | Clinical and functional assessment of glaucoma-associated mitochondrial gene variants to facilitate precision eye care | 000 | 3 | NIH | 12/4/2025 | $269,782 |
| | 2026 | 2026 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | K00DA060571 | Characterizing enhancers regulating transcription factor expression for cell-type specification across neurodevelopment | 002 | 4 | NIH | 1/30/2026 | $93,536 |
| | 2026 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | U01DP006822 | DP24-081 The Glaucoma and Retinopathy Screening Study | 01 | 2 | CDC | 11/13/2025 | $0 |
| | 2026 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01EY022305 | NEIGHBORHOOD Consortium for POAG Genetics | 000 | 13 | NIH | 1/13/2026 | $0 |
| | 2026 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R00MH127471 | Distributed Neural Activity Patterns Underlying Practice-Based Learning | 000 | 3 | NIH | 1/16/2026 | $0 |
| | 2026 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | K23DE029811 | Dissecting temporal and spatial dynamics of immunotherapy resistance | 000 | 5 | NIH | 1/23/2026 | $0 |
| | 2026 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | U01DP006822 | DP24-081 The Glaucoma and Retinopathy Screening Study | 01 | 2 | CDC | 11/13/2025 | $0 |
| | 2026 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | U01DP006822 | DP24-081 The Glaucoma and Retinopathy Screening Study | 01 | 2 | CDC | 11/13/2025 | $0 |
| | 2026 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01EY030973 | Neurophysiological Correlates of Visual Motion Processing in Cerebral Visual Impairment | 000 | 5 | NIH | 12/5/2025 | $0 |
| | 2026 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | K08EY031759 | The Fibrosis-Immunity Interface in Corneal Transplantation | 000 | 5 | NIH | 1/6/2026 | $0 |
| | 2026 | 2024 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | K08DC018575 | Mechanisms of Conductive Presbycusis in Humans | 000 | 5 | NIH | 1/22/2026 | $0 |
| | 2026 | 2023 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | U24DC013983 | NIDCD National Temporal Bone Hearing and Balance Pathology Resource Registry | 000 | 10 | NIH | 11/20/2025 | $0 |
| | 2026 | 2021 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01DC012545 | Central mechanisms and treatment response of sodium oxybate in spasmodic dysphonia and voice tremor | 000 | 10 | NIH | 1/5/2026 | $0 |
|
| Issue Date FY: 2025 ( Subtotal = $33,221,250 ) (Continued on the next page) |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01EY030088 | Metabolomics a Novel Tool for Investigating the Pathogenesis of Age-related Macular Degeneration | 001 | 6 | NIH | 7/29/2025 | $706,337 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01EY022305 | NEIGHBORHOOD Consortium for POAG Genetics | 000 | 13 | NIH | 2/14/2025 | $395,003 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01DC011805 | Imaging genetics of laryngeal dystonia | 000 | 15 | NIH | 7/1/2025 | $594,364 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | K12EY016335 | Harvard-Vision Clinical Scientist Development Program | 000 | 20 | NIH | 3/27/2025 | $3,990 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | T32DC000020 | Research Training in Otolaryngology | 000 | 33 | NIH | 6/13/2025 | $88,420 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01EB036978 | Fluorescence lifetime-based intraoperative imaging system for sarcoma surgeries | 001 | 1 | NIH | 8/21/2025 | $70,610 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01EB036978 | Fluorescence lifetime-based intraoperative imaging system for sarcoma surgeries | 000 | 1 | NIH | 1/13/2025 | $567,340 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R13DC013748 | International Hearing Aid Conference (IHCON) 2024 | 000 | 9 | NIH | 12/18/2024 | $100 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01DC020190 | Development of Gene Therapy for Hereditary Deafness using Rational Protein Engineering | 000 | 4 | NIH | 5/29/2025 | $655,725 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | U01DP006822 | DP24-081 The Glaucoma and Retinopathy Screening Study | 00 | 2 | CDC | 6/18/2025 | $750,000 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01NS124228 | Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia | 000 | 3 | NIH | 4/30/2025 | $674,349 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | P50DC015857 | Cochlear Synaptopathy: Prevalence, Diagnosis and Functional Consequences | 000 | 9 | NIH | 8/13/2025 | $2,684,343 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01EY036137 | Rapid Diagnosis of Ocular Infections using a Sensitive and Highly Multiplexed Broad Pathogen Detection Assay | 000 | 2 | NIH | 7/7/2025 | $425,000 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01EY036518 | Enhancing Glaucoma Risk Prediction through Advanced Genomics and Machine Learning | 000 | 2 | NIH | 9/22/2025 | $592,959 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01DC012142 | Perceptual implications of cochlear implant electrode-neuron interfaces | 000 | 15 | NIH | 5/23/2025 | $582,301 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01DC021606 | Improving Cochlear Implant Outcomes Through Modeling and Programming Strategies Based on Human Inner Ear Pathology | 000 | 3 | NIH | 7/29/2025 | $600,809 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | K23EY035342 | Genetics of central serous chorioretinopathy and choroidal thickening | 000 | 2 | NIH | 4/18/2025 | $276,856 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | U24DC020849 | Massachusetts Eye and Ear/ Harvard Initiative for the NIDCD National Human Ear Resource Network | 001 | 4 | NIH | 8/15/2025 | $595,000 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01EY033107 | CRISPR/Cas9-based gene editing approaches for the treatment of USH2A-associated diseases | 000 | 4 | NIH | 9/18/2025 | $505,799 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R00EY032110 | Elucidating the molecular and cellular mechanisms underlying cone survival in the peripheral retina in mouse models of Retinitis Pigmentosa | 000 | 5 | NIH | 4/4/2025 | $249,000 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01DC019353 | Adaptive closed-loop brain-computer interface therapeutic intervention in laryngeal dystonia | 000 | 5 | NIH | 7/28/2025 | $361,250 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01CA260857 | Multiplexed time domain fluorescence tomography of tumor biomarkers during immunotherapy | 001 | 6 | NIH | 7/22/2025 | $457,001 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | K08DC022696 | The Phex Pathway: Mechanisms Underlying a Meniere's Disease Subtype | 000 | 1 | NIH | 4/17/2025 | $194,400 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01DC017078 | Corticofugal Circuits for Active Listening | 000 | 9 | NIH | 7/2/2025 | $703,354 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01DC021434 | Vestibular dysfunction in patients with sporadic vestibular schwannomas and NF2-related schwannomatosis. | 000 | 1 | NIH | 4/16/2025 | $620,240 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01DC021996 | Advancement of an Implantable Microphone | 000 | 1 | NIH | 4/8/2025 | $674,021 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01DC016079 | Middle Ear Nonlinearity in High Intensity Sound: Impact on Hearing Damage and Protection | 000 | 9 | NIH | 3/4/2025 | $362,711 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01DC016079 | Middle Ear Nonlinearity in High Intensity Sound: Impact on Hearing Damage and Protection | 001 | 9 | NIH | 6/3/2025 | $40,301 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | K08DC019128 | Neural Mechanisms Underlying the Auditory Phenotype of Mild Traumatic Brain Injury | 000 | 5 | NIH | 11/26/2024 | $186,095 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01EY020928 | Genetic and Environmental Risk Factors for Exfoliation Syndrome and Glaucoma | 000 | 13 | NIH | 9/17/2025 | $426,396 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01EY014943 | Long-term Follow-up of the Systemic Immunosuppressive Therapy for Eye Diseases Cohort | 001 | 12 | NIH | 8/29/2025 | $0 |
| | 2025 | 2025 | MASSACHUSETTS EYE AND EAR INFIRMARY | 243 CHARLES ST | BOSTON | MA | 02114-3002 | SUFFOLK | USA | R01EY014943 | Long-term Follow-up of the Systemic Immunosuppressive Therapy for Eye Diseases Cohort | 000 | 12 | NIH | 8/15/2025 | $2,236,075 |
|
